use
new
antibiotic
agents
chronic
pulmonary
disease
modern
advances
development
antimicrobial
agents
chemotherapy
made
available
potent
aminoglycoside
antibiotics
effective
ones
come
effectiveness
p
aeruginosa
great
contribution
patients
cystic
fibrosis
chronic
disorders
development
carbenicillin
augmented
effectiveness
aminoglycoside
antibiotics
ticarcillin
similar
carbenicillin
play
similar
role
antibiotic
therapy
cephalosporins
serve
alternative
agents
principally
antistaphylococcal
activity
urgently
need
potent
antibiotic
agent
p
aeruginosa
given
oral
route
tmp
smx
combination
potent
chemotherapeutic
agent
administered
oral
route
effective
treatment
p
carinii
pneumonia
common
owing
extended
survival
patients
leukemia
malignancies
allografts
prone
develop
infections
immunosuppressive
therapy
